عرض بسيط للتسجيلة

المؤلفSuleiman, Muna
المؤلفAl Najjar, Afnan
المؤلفZakaria, Zain Z.
المؤلفAhmed, Rashid
المؤلفYalcin, Huseyin C.
المؤلفKorashy, Hesham M.
المؤلفUddin, Shahab
المؤلفRiaz, Sadaf
المؤلفAbdulrahman, Nabeel
المؤلفMraiche, Fatima
تاريخ الإتاحة2023-09-26T05:04:06Z
تاريخ النشر2023-01-01
اسم المنشورJournal of Cardiovascular Translational Research
المعرّفhttp://dx.doi.org/10.1007/s12265-023-10431-4
الاقتباسSuleiman, M., Al Najjar, A., Zakaria, Z.Z. et al. The Role of p90 Ribosomal S6 Kinase (RSK) in Tyrosine Kinase Inhibitor (TKI)-Induced Cardiotoxicity. J. of Cardiovasc. Trans. Res. (2023). https://doi.org/10.1007/s12265-023-10431-4
الرقم المعياري الدولي للكتاب19375387
معرّف المصادر الموحدhttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85171448280&origin=inward
معرّف المصادر الموحدhttp://hdl.handle.net/10576/47959
الملخصTargeted therapy, such as tyrosine kinase inhibitors (TKIs), has been approved to manage various cancer types. However, TKI-induced cardiotoxicity is a limiting factor for their use. This issue has raised the need for investigating potential cardioprotective techniques to be combined with TKIs. Ribosomal S6-kinases (RSKs) are a downstream effector of the mitogen-activated-protein-kinase (MAPK) pathway; specific RSK isoforms, such as RSK1 and RSK2, have been expressed in cancer cells, in which they increase tumour proliferation. Selective targeting of those isoforms would result in tumour suppression. Moreover, activation of RSKs expressed in the heart has resulted in cardiac hypertrophy and arrhythmia; thus, inhibiting RSKs would result in cardio-protection. This review article presents an overview of the usefulness of RSK inhibitors that can be novel agents to be assessed in future research for their effect in reducing cancer proliferation, as well as protecting the heart from cardiotoxicity induced by TKIs. Graphical Abstract: [Figure not available: see fulltext.]
اللغةen
الناشرSpringer
الموضوعAnticancer
Cardiotoxicity
p90 ribosomal S6 kinase
Tyrosine kinase inhibitors
العنوانThe Role of p90 Ribosomal S6 Kinase (RSK) in Tyrosine Kinase Inhibitor (TKI)-Induced Cardiotoxicity
النوعArticle Review
dc.accessType Full Text


الملفات في هذه التسجيلة

Thumbnail

هذه التسجيلة تظهر في المجموعات التالية

عرض بسيط للتسجيلة